| METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma T Li, PS Hu, Z Zuo, JF Lin, X Li, QN Wu, ZH Chen, ZL Zeng, F Wang, ... Molecular cancer 18, 1-15, 2019 | 558 | 2019 |
| N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis RX Chen, X Chen, LP Xia, JX Zhang, ZZ Pan, XD Ma, K Han, JW Chen, ... Nature communications 10 (1), 4695, 2019 | 472 | 2019 |
| Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib … F Wang, XL Wei, FH Wang, N Xu, L Shen, GH Dai, XL Yuan, Y Chen, ... Annals of Oncology 30 (9), 1479-1486, 2019 | 372 | 2019 |
| Evaluation of POLE and POLD1 mutations as biomarkers for immunotherapy outcomes across multiple cancer types F Wang, Q Zhao, YN Wang, Y Jin, MM He, ZX Liu, RH Xu JAMA oncology 5 (10), 1504-1506, 2019 | 337 | 2019 |
| Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression D Chen, Y Lu, J Zhang, X Wei, F Wang, Z Zeng, Z Pan, Y Yuan, F Wang, ... Theranostics 7 (19), 4836, 2017 | 265 | 2017 |
| Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression D Chen, H Ju, Y Lu, L Chen, Z Zeng, D Zhang, H Luo, F Wang, M Qiu, ... Journal of experimental & clinical cancer research 35, 1-13, 2016 | 265 | 2016 |
| CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis Y Wang, Z Zeng, J Lu, Y Wang, Z Liu, M He, Q Zhao, Z Wang, T Li, Y Lu, ... Oncogene 37 (46), 6025-6040, 2018 | 245 | 2018 |
| Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial ZX Wang, C Cui, J Yao, Y Zhang, M Li, J Feng, S Yang, Y Fan, J Shi, ... Cancer cell 40 (3), 277-288. e3, 2022 | 221 | 2022 |
| High incidence of hepatitis B virus infection in B‐cell subtype non‐Hodgkin lymphoma compared with other cancers F Wang, R Xu, B Han, Y Shi, H Luo, W Jiang, T Lin, H Huang, Z Xia, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 172 | 2007 |
| Novel role of NOX in supporting aerobic glycolysis in cancer cells with mitochondrial dysfunction and as a potential target for cancer therapy W Lu, Y Hu, G Chen, Z Chen, H Zhang, F Wang, L Feng, H Pelicano, ... PLoS biology 10 (5), e1001326, 2012 | 163 | 2012 |
| A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio X Wei, F Wang, D Zhang, M Qiu, C Ren, Y Jin, Y Zhou, D Wang, M He, ... BMC cancer 15, 1-11, 2015 | 157 | 2015 |
| Small mitochondria-targeting molecules as anti-cancer agents F Wang, MA Ogasawara, P Huang Molecular aspects of medicine 31 (1), 75-92, 2010 | 146 | 2010 |
| Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer DS Wang, ZX Liu, YX Lu, H Bao, X Wu, ZL Zeng, Z Liu, Q Zhao, CY He, ... Gut 68 (7), 1152-1161, 2019 | 145 | 2019 |
| Identification of microRNA‐214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression D Chen, Z Wang, Z Zeng, W Wu, D Zhang, H Luo, F Wang, M Qiu, D Wang, ... Hepatology 60 (2), 598-609, 2014 | 138 | 2014 |
| Systematic analysis of the aberrances and functional implications of ferroptosis in cancer Z Liu, Q Zhao, ZX Zuo, SQ Yuan, K Yu, Q Zhang, X Zhang, H Sheng, ... Iscience 23 (7), 2020 | 135 | 2020 |
| Effective elimination of cancer stem cells by a novel drug combination strategy S Yuan, F Wang, G Chen, H Zhang, L Feng, L Wang, H Colman, ... Stem cells 31 (1), 23-34, 2013 | 106 | 2013 |
| Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds G Chen, F Wang, D Trachootham, P Huang Mitochondrion 10 (6), 614-625, 2010 | 105 | 2010 |
| Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkers HX Wu, ZX Wang, Q Zhao, DL Chen, MM He, LP Yang, YN Wang, Y Jin, ... Annals of translational medicine 7 (22), 2019 | 103 | 2019 |
| Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer G Chen, J Peng, Q Xiao, HX Wu, X Wu, F Wang, L Li, P Ding, Q Zhao, Y Li, ... Journal of hematology & oncology 14, 1-11, 2021 | 100 | 2021 |
| ME1 regulates NADPH homeostasis to promote gastric cancer growth and metastasis YX Lu, HQ Ju, ZX Liu, DL Chen, Y Wang, Q Zhao, QN Wu, Z Zeng, HB Qiu, ... Cancer research 78 (8), 1972-1985, 2018 | 100 | 2018 |
